Full Length Research Paper
References
|
Belisário AR, Martins ML, Brito AMS, Rodrigues CV, Silva CM, Viana MB (2010). β-Globin Gene Cluster Haplotypes in a Cohort of 221 Children with Sickle Cell Anemia or Sβ0-Thalassemia and Their Association with Clinical and Hematological Features. Acta Aematologica 124(3):162-170. |
|
|
Bernaudin F, Arnaud C, Kamdem A, Hau I, Lelong F, Epaud R (2018). Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea. Blood Advances 2(6):626-637. |
|
|
Bhanushali AA, Patra PK, Nair D, Verma H, Das BR (2015). Genetic variant in the BCL11A (rs1427407), but not HBS1-MYB (rs6934903) loci associated with fetal hemoglobin levels in Indian sickle cell disease patients. Blood Cells, Molecules, and Diseases 54(1):4-8. |
|
|
Boutchi M (2015). Hémolyse chronique des sujets drépanocytaires SS et SC en phase stationnaire : étude comparative au centre national de référence de la drépanocytose à Niamey. African and Malagasy Review of Scientific Research/Health Sciences 3(1):25-29. |
|
|
Cardoso GL, Diniz IG, Martins da Silva ANL, Cunha DA, da Silva Junior JS, Carvalho Uchôa CT (2014). DNA polymorphisms at BCL11A, HBS1L-MYB, and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil. Blood Cells, Molecules and Diseases 53(4):176-179. |
|
|
Chies JA, Nardi NB (2001). Sickle cell disease: a chronic inflammatory condition. Medical hypotheses 57(1):46-50. |
|
|
Creary LE, Ulug P, Menzel S, McKenzie CA, Hanchard NA, Taylor V (2009). Genetic Variation on Chromosome 6 Influences F Cell Levels in Healthy Individuals of African Descent and HbF Levels in Sickle Cell Patients. PLoS One 4(1):e4218. |
|
|
Dahmani F, Benkirane S, Kouzih J, Woumki A, Mamad H, Masrar A (2016). Etude de l'hémogramme dans la drépanocytose homozygote : à propos de 87 patients. The Pan African Medical Journal 25:240. |
|
|
Dahmani F, Benkirane S, Kouzih J, Woumki A, Mamad H, Masrar A (2017). Profil épidémiologique des hémoglobinopathies : étude autour du cas index : étude transversale descriptive. The Pan African Medical Journal 27(150). |
|
|
Danjou F, Francavilla M, Anni F, Satta S, Demartis FR, Perseu L, Manca M, Sollaino MC, Manunza L, Mereu E, Marceddu G (2015). A genetic score for the prediction of beta-thalassemia severity. Haematologica 100(4):452-457. |
|
|
Diagne I, Ndiaye O, Moreira C, Signate-Sy H, Camara B, Diouf S, Diack-Mbaye A, Ba M, Sarr M, Sow D, Fall M (2000). Major sickle cell syndromes in pediatrics in Dakar (Senegal). Archives of Pediatrics 7(1):16-24. |
|
|
Diop S, Thiam D, Cisse M, Toure-Fall AO, Fall K, Diakhate L (1999). New results in clinical severity of homozygous sickle cell anemia, in Dakar, Senegal. Hematology and Cell Therapy 41(5):217-221. |
|
|
Doupa D, Djite M, Gueye PM, Seck M, Faye BF, Seck SM, Diallo F, Ndiaye A, Samba A, Cisse F, Diatta A (2017). Profil biochimique et hématologique des patients drépanocytaires homozygotes en phase stationnaire au centre National de Transfusion Sanguine de Dakar. International Journal of Biological and Chemical Sciences 11(4): 1706-1715. |
|
|
Gilman JG, Huisman THJ (1985). DNA Sequence Variation Associated with Elevated Fetal Gγ Globin Production. Blood 66(4):783-787. |
|
|
Gueye Tall F, Martin C, Malick Ndour EH, Déme Ly I, Renoux C, Chillotti L, Veyrenche N, Connes P, Madieye Gueye P, Ndiaye Diallo R, Lacan P (2017). Genetic Background of the Sickle Cell Disease Pediatric Population of Dakar, Senegal, and Characterization of a Novel Frameshift β-Thalassemia Mutation [HBB: c.265_266del; p. Leu89Glufs*2]. Hemoglobin 41(2):89-95. |
|
|
Gueye Tall F, Ndour EHM, Ly Dème I, Ndiaye Diallo R, Gueye PM, Diop P A (2017). Prévalence de l'alpha-thalassémie au sein d'une population drépanocytaire sénégalaise. Revue. CAMES SANTE 9(35):40-46. |
|
|
Jeanne L (2010). Place of capillary electrophoresis in the diagnosis and monitoring of haemoglobinopathies. Option/Bio 434(21):17-20. |
|
|
Labie D (2000). Pourquoi l'hémoglobine F est-elle élevée dans les thalassémies? L'hétérozygotie E/beta-thalassémie comme modèle. Hematology 216(5). |
|
|
Lederberg J (1999). JBS Haldane (1949) on infectious disease and evolution. Genetics 153(1):1-3. |
|
|
Lettre G, Sankaran VG, Bezerra MA, Araujo AS, Uda M, Sanna S (2008). DNA polymorphisms at the BCL11A, HBS1L-MYB, and -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proceedings of the National Academy of Sciences USA 105(33):11869-11874. |
|
|
Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T (2003). Bcl11a is essential for normal lymphoid development. Nature Immunology 4(6):525-32. |
|
|
Makani J, Menzel S, Nkya S, Cox SE, Drasar E, Soka D (2011). Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia. Blood 117(4):1390-1392. |
|
|
Mattioni S, Stojanovic KS, Girot R, Lionnet F (2016). Sickle cell disease in France. Francophone Review of Laboratories (481):61-66. |
|
|
Mtatiro SN, Singh T, Rooks H, Mgaya J, Mariki H, Soka D (2014). Genome-Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania. PLoS One 9(11):e111464. |
|
|
Muszlak M, Pissard S, Badens C, Chamouine A, Maillard O, Thuret I (2015). Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island. Hemoglobin 39(3):156-61. |
|
|
Pule GD, Ngo Bitoungui VJ, Chemegni BC, Kengne AP, Antonarakis S, Wonkam A (2015). Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions. Omics: A Journal of Integrative Biology 19(10):627-631. |
|
|
Somervaille T (2001). Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Journal of the Royal Society of Medicine 94(11):602-603. |
|
|
Steinberg MH, Sebastiani P (2012). Genetic modifiers of sickle cell disease. American Journal of Hematology 87(8):795-803. |
|
|
Tchokoteu PF (2004). La drepanocytose de l'enfant : aspects cliniques et prise en charge. Clinics in Mother and Child Health 9-21. |
|
|
Thein SL, Menzel S, Lathrop M, Garner C (2009). Control of fetal hemoglobin: new insights emerging from genomics and clinical implications. Human Molecular Genetics 18(R2):R216-23. |
|
|
Thiam L, Dramé A, Coly IZ, Diouf FN, Seck N, Boiro D (2017). Profils épidémiologiques, cliniques et hématologiques de la drépanocytose homozygote SS en phase intercritique chez l'enfant à Ziguinchor, Sénégal. Revue d'Oncologie Hématologie Pédiatrique 5(3):130-135. |
|
|
Wonkam A, Monika K, Bitoungui VJN, Chemegni BC, Chimusa ER, Dandara C (2018). Clinical and genetic factors are associated with pain and hospitalization rates in sickle cell anemia in Cameroon. British Journal of Haematology 180(1):134-146. |
|
|
Wonkam A, Ngo Bitoungui VJ, Vorster AA, Ramesar R, Cooper RS, Tayo B (2014). Association of Variants at BCL11A and HBS1L-MYB with Hemoglobin F and Hospitalization. PLoS One 9(3):e92506. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
